Identification of human dopamine receptors agonists from Chinese herbs

Acta Pharmacologica Sinica

Volumn 28, Issue 1, 2007, Pages 132-139

  Zhang, Yi Lin ^a,b,c   Zhang, Hai Qing ^a,b,c   Liu, Xiao Yu ^c   Hua, Shi Neng ^c   Zhou, Lu Bing ^c   Yu, Jun ^b   Tan, Xue Hai ^c  

^a UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c HD Biosciences Co Ltd   (China)

Author keywords

Dopamine receptors; High throughput screening; Hypertension; Natural products

Indexed keywords

BETA LACTAMASE; CRE RECOMBINASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; HD 0059; HD 0059H01; HD 0522; HD 0522H01; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL STRAIN HEK293; CHINESE HERB; CONTROLLED STUDY; DRUG IDENTIFICATION; EMBRYO; EVALUATION; GENE LIBRARY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; REPORTER GENE; SAMPLE; STRUCTURE ACTIVITY RELATION;

EID: 33845976988     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00460.x     Document Type: Article

References (43)

1. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 1998; 80: 149-82.
2. Jose PA, Eisner GM, Felder RA. Regulation of blood pressure by dopamine receptors. Nephron Physiol 2003; 95: 19-27.
3. Jose PA, Eisner GM, Drago J, Carey RM, Felder RA. Dopamine receptor signaling defects in spontaneous hypertension. Am J Hypertens 1996; 9: 400-5.
4. Sibley DR. New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 1999; 39: 313-41.
5. Uh M, White BH, Sidhu A. Alteration of association of agonistactivated renal D1(A) dopamine receptors with G proteins in proximal tubules of the spontaneously hypertensive rat. J Hypertens 1998; 16: 1307-13.
6. Albrecht FE, Xu J, Moe OW, Hopfer U, Simonds WF, Orlowski J, et al. Regulation of NHE3 activity by G protein subunits in renal brush-border membranes. Am J Physiol Regul Integr Comp Physiol 2000; 278: R1064-73.
7. van den Buuse M. Role of the mesolimbic dopamine system in cardiovascular homeostasis. Stimulation of the ventral tegmental area modulates the effect of vasopressin on blood pressure in conscious rats. Clin Exp Pharmacol Physiol 1998; 25: 661-8.
8. Sowers JR, Viosca SP, Windsor C, Korenman SG. Influence of dopaminergic mechanisms on 24-hour secretory patterns of prolactin, luteinizing hormone and testosterone in recumbent men. J Endocrinol Invest 1983; 6: 9-15.
9. +-ATPase during high-salt diet in young but not in adult rats. Am J Physiol 1998; 275: G1317-23.
10. Roitman MF, Schafe GE, Thiele TE, Bernstein IL. Dopamine and sodium appetite: antagonists suppress sham drinking of NaCl solutions in the rat. Behav Neurosci 1997; 111: 606-11.
11. Baines AD, Drangova R. Does dopamine use several signal pathways to inhibit Na-Pi transport in OK cells? J Am Soc Nephrol 1998; 9: 1604-12.
12. Feschenko MS, Stevenson E, Sweadner KJ. Interaction of protein kinase C and cAMP-dependent pathways in the phosphorylation of the Na,K-ATPase. J Biol Chem 2000; 275: 34693-700.
13. Hussain T, Lokhandwala MF. Dopamine-1 receptor G-protein coupling and the involvement of phospholipase A2 in dopamine-1 receptor mediated cellular signaling mechanisms in the proximal tubules of SHR. Clin Exp Hypertens 1997; 19: 131-40.
14. Lin F, Abraham NG, Schwartzman ML. Cytochrome P450 arachidonic acid omega-hydroxylation in the proximal tubule of the rat kidney. Ann N Y Acad Sci 1994; 744: 11-24.
15. Li XX, Albrecht FE, Robillard JE, Eisner GM, Jose PA. Gbeta regulation of Na/H exchanger-3 activity in rat renal proximal tubules during development. Am J Physiol Regul Integr Comp Physiol 2000; 278: R931-6.
16. +-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased activity in epithelial cells. J Biol Chem 1999; 274: 1920-7.
17. Albrecht FE, Drago J, Felder RA, Printz MP, Eisner GM, Robillard JE, et al. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 1996; 97: 2283-8.
18. de Vries PA, Navis G, de Jong PE, de Zeeuw D, Kluppel CA. Impaired renal vascular response to a D1-like receptor agonist but not to an ACE inhibitor in conscious spontaneously hypertensive rats. J Cardiovasc Pharmacol 1999; 34: 191-8.
19. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, et al. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 2002; 99: 3872-7.
20. Hussain T, Lokhandwala MF. Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+,K(+)-ATPase in kidney of spontaneously hypertensive rats. Clin Exp Hypertens 1996; 18: 963-74.
21. Debska-Slizien A, Ho P, Drangova R, Baines AD. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. J Am Soc Nephrol 1994; 5: 1125-32.
22. Chatziantoniou C, Ruan X, Arendshorst WJ. Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc Natl Acad Sci USA 1995; 92: 2924-8.
23. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Bai RK, et al. D5 dopamine receptor regulation of phospholipase D. Am J Physiol Heart Circ Physiol 2005; 288: H55-61.
24. Yang Z, Sibley DR, Jose PA. D5 dopamine receptor knockout mice and hypertension. J Recept Signal Transduct Res 2004; 24: 149-64.
25. Asico LD, Ladines C, Fuchs S, Accili D, Carey RM, Semeraro C, et al. Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension. J Clin Invest 1998; 102: 493-8.
26. Bek MJ, Wang X, Asico LD, Jones JE, Zheng S, Li X, et al. Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension 2006; 47: 288-95.
27. Li XX, Bek M, Asico LD,Yang ZW, Rubinstein M,Grandy DK, et al. Disruption of the D(2) dopamine receptor produces adrenergic and endothelin B receptor-dependent hypertension. Zhonghua Yi Xue Za Zhi 2002; 82: 703-7. Chinese.
28. + exchanger activity in normotensive and spontaneously hypertensive rat proximal tubular epithelial cells. Br J Pharmacol 2004; 142: 1343-53.
29. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM. Evidence that dopamine-2 mechanisms control renal function. Am J Physiol 1990; 259: F793-800.
30. Siragy HM, Felder RA, Peach MJ, Carey RM. Intrarenal DA2 dopamine receptor stimulation in the conscious dog. Am J Physiol 1992; 262: F932-8.
31. Oparil S,Aronson S,Deeb GM,Epstein M,Levy JH,Luther RR, et al. Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises. Am J Hypertens 1999; 12: 653-64.
32. Colvin JR, Chaudhri S, Kenny GN. Evaluation of dopexamine hydrochloride as an anti-hypertensive agent after cardiac surgery. Int J Clin Monit Comput 1991; 8: 95-100.
33. Ghosh S, Gray B, Oduro A, Latimer RD. Dopexamine hydrochloride: pharmacology and use in low cardiac output states. J Cardiothorac Vasc Anesth 1991; 5: 382-9.
34. Bindseil KU, Jakupovic J, Wolf D, Lavayre J, Leboul J, van der Pyl D. Pure compound libraries; a new perspective for natural product based drug discovery. Drug Discov Today 2001; 6: 840-7.
35. Zlokarnik G. Fusions to beta-lactamase as a reporter for gene expression in live mammalian cells. Methods Enzymol 2000; 326: 221-44.
36. Kunapuli P, Ransom R, Murphy KL, Pettibone D, Kerby J, Grimwood S, et al. Development of an intact cell reporter gene beta-lactamase assay for G protein-coupled receptors for high-throughput screening. Anal Biochem 2003; 314: 16-29.
37. Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 1999; 4: 67-73.
38. Zlokarnik G, Negulescu PA, Knapp TE, Mere L, Burres N, Feng L, et al. Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 1998; 279: 84-8.
39. Peekhaus NT,Ferrer M,Chang T,Kornienko O,Schneeweis JE, Smith TS, et al. A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format. Assay Drug Dev Technol 2003; 1: 789-800.
40. Zuck P,Murray EM,Stec E,Grobler JA,Simon AJ,Strulovici B, et al. A cell-based beta-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication. Anal Biochem 2004; 334: 344-55.
41. Rishton GM. Failure and success in modern drug discovery: guiding principles in the establishment of high probability of success drug discovery organizations. Med Chem 2005; 1: 519-27.
42. Offermanns S, Simon MI. G alpha 15 and G alpha 16 couple a wide variety of receptors to phospholipase C. J Biol Chem 1995; 270: 15175-80.
43. Liu AM, Ho MK, Wong CS, Chan JH, Pau AH, Wong YH. Galpha (16/z) chimeras efficiently link a wide range of G protein-coupled receptors to calcium mobilization. J Biomol Screen 2003; 8: 39-49.